Table 1 Best CDKi’s identified in this study for selective target engagement in live cells.

From: Quantifying CDK inhibitor selectivity in live cells

CDK

Compound

On target potencya

Collateral CDK (potency)

CDK2

NU6102

290 nM

STb

CDK3

RO-3306

200 nM

CDK7 (690 nM)

CDK4/6

Palbociclib

10 nM/2 nM

STb

CDK4/6

Ribociclib

29 nM/31 nM

STb

CDK7

THZ1

90 nM

CDK11a (300 nM)

CDK7

BS-181

470 nM

STb

CDK9

BAY-1251152

9 nM

STb

CDK9

Atuveciclib

150 nM

STb

CDK8/19

CCT251545

6 nM/6 nM

STb

CDK8/19

CCT251545 analog

6 nM/10 nM

STb

CDK8/19

BMS-265246

0.7 nM/1.5 nM

CDK3 (10 nM)

CDK8/19

K08361

3 nM/1.4 nM

CDK7 (63 nM)

CDK12

THZ531

770 nM

STb

  1. aPotency represents the mean of 3 independent experiments. For S.E.M., see Supplementary Data 2 or 3.
  2. bSub Threshold: no collateral CDKs were detected with potency below the cutoff of 1 µM.